September 18-20, 2017
Ocean Place Resort, Long Branch, NJ

> 2017 Exhibitors

> 2016 Exhibitors

> 2014 Exhibitors

Download Exhibitor Manual

Download Exhibitor Electric Form

ChemOutsourcing Banner To Alert Contacts You’re Attending

2017 Exhibitor List

read: buyers and suppliers together

Exhibitor List As Of July 22, 2017

Look for exhibitors according to their first letter.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Show All

 

Kalexsyn, Inc.
Kaneka Americas
Kemio Solutions
Kyongbo Pharm

Kalexsyn, Inc. [ company website ]

Kalexsyn provides clients with proven, experienced medicinal chemists: IP-enabling SAR, custom synthesis, stable label synthesis, early API scale-up and process improvement. Full analytical capabilities onsite. We deliver:
  • Real medicinal chemistry: Medchem experience built from years of experiential practice.
  • Problem solving: Able to problem solve tough synthetic challenges in conjunction with clients. You can ask them.
  • Communication: Information provided in an agreed upon format, on time every time. Our international client base from Osaka to Vienna is reflective of our successful communication skills.

Kaneka Americas [ company website ]

Utilizing enzyme-mediated synthesis and fermentation technology along with a wide variety of advanced organic synthetic methodologies, Kaneka has established itself as a leading innovator and reliable manufacturer of chiral pharmaceutical intermediates and fine chemicals.

Kemio Solutions [ company website ]

Kyongbo Pharm [ company website ]

Kyongbo Pharmaceutical Co., Ltd (Kyongbo), an affiliate of Chong Kun Dang pharmaceutical Corp., is a leading pharmaceutical company in Korea. Kyongbo is specialized in manufacturing APIs for Anti-infectives, Anti-hypertension, Anti-cardiovascular, targeted Anti- cancer and General APIs and etc. Kyongbo offers the customized CMO & CRO business (Clinical stage) to the multinational companies with integrated technical resources and dedicated facilities of Cephalosporins, Carbapenems and General APIs which are satisfied with cGMP standards. With constant efforts to be a qualified cGMP manufacturer, Kyongbo has 5 COS certified products in EU, 10 DMFs in USFDA and 47 APIs registered in PMDA of Japan. Kyongbo has “High-Potency 1” facility with isolation system dedicated to Cytotoxic Anti-cancer APIs. It is classified in Category 4 (SafeBridge OEL Categorization). Kyongbo is ready to be a suitable partner including CMO & CRO business through cGMP facilities including “High-Potency1”, and will be appropriate with your existing and future products.